These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 12924613)

  • 1. Differential indication of lipoprotein apheresis during pregnancy.
    Klingel R; Göhlen B; Schwarting A; Himmelsbach F; Straube R
    Ther Apher Dial; 2003 Jun; 7(3):359-64. PubMed ID: 12924613
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pregnancy in homozygous familial hypercholesterolemia--Importance of LDL-apheresis.
    Blaha M; Lanska M; Blaha V; Boudys L; Zak P
    Atheroscler Suppl; 2015 May; 18():134-9. PubMed ID: 25936317
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A case report of the cascade filtration system: a safe and effective method for low-density lipoprotein apheresis during pregnancy.
    Ertorer ME; Guvenc B; Haydardedeoglu B; Tekinturhan F
    Ther Apher Dial; 2008 Oct; 12(5):396-400. PubMed ID: 18937724
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term effect of low-density lipoprotein apheresis in patients with homozygous familial hypercholesterolemia.
    Makino H; Harada-Shiba M
    Ther Apher Dial; 2003 Aug; 7(4):397-401. PubMed ID: 12887721
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipidfiltration--safe and effective methodology to perform lipid-apheresis.
    Klingel R; Mausfeld P; Fassbender C; Goehlen B
    Transfus Apher Sci; 2004 Jun; 30(3):245-54. PubMed ID: 15172630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Indication of low-density lipoprotein apheresis in severe hypercholesterolemia and its atherosclerotic vascular complications: dextran sulfate cellulose low-density lipoprotein apheresis.
    Keller C
    Ther Apher Dial; 2003 Jun; 7(3):345-9. PubMed ID: 12924611
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-density lipoprotein apheresis: an overview.
    Bambauer R; Schiel R; Latza R
    Ther Apher Dial; 2003 Aug; 7(4):382-90. PubMed ID: 12887719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Three different schedules of low-density lipoprotein apheresis compared with plasmapheresis in patients with homozygous familial hypercholesterolemia.
    Berger GM; Firth JC; Jacobs P; Wood L; Marais AD; Horak A
    Am J Med; 1990 Feb; 88(2):94-100. PubMed ID: 2105647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Severe dyslipidemia in pregnancy: The role of therapeutic apheresis.
    Russi G
    Transfus Apher Sci; 2015 Dec; 53(3):283-7. PubMed ID: 26626968
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HELP LDL-apheresis in two cases of familial hypercholesterolemic pregnant women.
    Anedda S; Mura S; Marcello C; Pintus P
    Transfus Apher Sci; 2011 Feb; 44(1):21-4. PubMed ID: 21257349
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Treatment of severe hypercholesterolemia by LDL-apheresis: cholesterol-lowering effect and clinical evaluation.
    Saito Y; Shinomiya M; Shirai K; Yoshida S
    Beitr Infusionsther; 1988; 23():160-71. PubMed ID: 2484772
    [No Abstract]   [Full Text] [Related]  

  • 12. Long-term effect of low-density lipoprotein apheresis in patients with heterozygous familial hypercholesterolemia.
    Higashikata T; Mabuchi H
    Ther Apher Dial; 2003 Aug; 7(4):402-7. PubMed ID: 12887722
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of mipomersen on LDL-cholesterol in patients with severe LDL-hypercholesterolaemia and atherosclerosis treated by lipoprotein apheresis (The MICA-Study).
    Waldmann E; Vogt A; Crispin A; Altenhofer J; Riks I; Parhofer KG
    Atherosclerosis; 2017 Apr; 259():20-25. PubMed ID: 28279833
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Low-density lipoprotein apheresis as long-term treatment for children with homozygous familial hypercholesterolemia.
    Zwiener RJ; Uauy R; Petruska ML; Huet BA
    J Pediatr; 1995 May; 126(5 Pt 1):728-35. PubMed ID: 7751996
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defining the role of lipoprotein apheresis in the management of familial hypercholesterolemia.
    Lee WP; Datta BN; Ong BB; Rees A; Halcox J
    Am J Cardiovasc Drugs; 2011 Dec; 11(6):363-70. PubMed ID: 22149315
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The lipid-lowering effects of lomitapide are unaffected by adjunctive apheresis in patients with homozygous familial hypercholesterolaemia - a post-hoc analysis of a Phase 3, single-arm, open-label trial.
    Stefanutti C; Blom DJ; Averna MR; Meagher EA; Theron Hd; Marais AD; Hegele RA; Sirtori CR; Shah PK; Gaudet D; Vigna GB; Sachais BS; Di Giacomo S; du Plessis AM; Bloedon LT; Balser J; Rader DJ; Cuchel M;
    Atherosclerosis; 2015 Jun; 240(2):408-14. PubMed ID: 25897792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Low density lipoprotein apheresis in pediatric patients with homozygous familial hypercholesterolemia.
    Coker M; Ucar SK; Simsek DG; Darcan S; Bak M; Can S
    Ther Apher Dial; 2009 Apr; 13(2):121-8. PubMed ID: 19379151
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Selective apheresis of low-density lipoproteins in a child].
    Griskevicius A; Audzijoniene J; Petrulioniene Z; Laucevicius A
    Medicina (Kaunas); 2007; 43(11):879-82. PubMed ID: 18084145
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Current insights into the German lipoprotein apheresis standard: PCSK9-inhibitors, lipoprotein apheresis or both?
    Schettler VJJ; Ringel J; Jacob S; Julius U; Klingel R; Heigl F; Roeseler E; Grützmacher P;
    Atheroscler Suppl; 2017 Nov; 30():44-49. PubMed ID: 29096860
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term effect of low-density lipoprotein apheresis on plasma lipoproteins and coronary heart disease in native vessels and coronary bypass in severe heterozygous familial hypercholesterolemia.
    Richter WO; Donner MG; Höfling B; Schwandt P
    Metabolism; 1998 Jul; 47(7):863-8. PubMed ID: 9667236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.